Hongkun Wang's Publications

  1. Wang H, Wang Y, Kota KK, Sun B, Kallakury B, Mikhail NN, Sayed D, Mokhtar A, Maximous D, Yassin EH, Sun SX, Chen X, Loffredo CA, Zheng Y. Chromosomal aberrations in blood lymphocytes predict the risk of urothelial and squamous cell carcinoma of bladder. 2017. Scientific Reports. In Press.

  2. Kim K, Jha R, Prins PA, Wang H, Chacha M, Hartley ML, He AR. Regorafenib in advanced hepatocellular carcinoma (HCC): considerations for treatment. Cancer Chemother Pharmacol. 2017. doi:10.1007/s00280-017-3431-5. PubMed PMID: 28932966.

  3. Fu Y, Silverstein S, McCutcheon JN, Dyba M, Nath RG, Aggarwal M, Coia H, Bai A, Pan J, Jiang J, Kallakury B, Wang H, Zhang YW, Giaccone G, He AR, Chung FL. An endogenous DNA adduct as a prognostic biomarker for hepatocarcinogenesis and its prevention by Theaphenon E in mice. Hepatology. 2017. doi: 10.1002/hep.29380. PubMed PMID: 28718980.

  4. Baker M, Wang H, Rowley S, Cai L, Pecora AL, Skarbnik A, Vesole D, Adler-Brecher B, Kim D, Donato ML. Comparative Outcomes after Haploidentical or Unrelated Donor Bone Marrow or Blood Stem Cell Transplantation in Adult Patients with Hematological Malignancies. Biology of Blood and Marrow Transplantation. 2016. 22(11):2047-2055, doi:10.1016/j.bbmt.2016.08.003. Epub 2016 Aug 10. PubMed PMID: 27522040.

  5. Galli S, Naranjo A, Van Ryn C, Tilan J, Trinh E, Yang C, Tsuei J, Hong S, Wang H, IzyckaSwieszewska E, Kitlinska J. Neuropeptide Y as a biomarker and therapeutic target for neuroblastoma. The American Journal of Pathology. 2016. 186(11):3040-3053. doi: 10.1016/j.ajpath.2016.07.019. Epub 2016 Oct 12. PubMed PMID: 27743558.

  6. Kim A, Unger K, Wang H, Pishvaian M. Incorporating Yttrium-90 Trans-Arterial Radioembolization (TARE) in the Treatment of Metastatic Pancreatic Adenocarcioma: A Single Center Experience. BioMed Central Cancer. 2016. 16:492. doi: 10.1186/s12885-016-2552-2. PubMed Central PMCID: PMC4950251.

  7. Wang Y, Sun H, Wang H, Liu A. Efficiency of Targeted Clinical Trials with Pre-Post Designs -Efficiency of Targeted Trials. Statistics in Biosciences. In press.

  8. Ujjani CS, Hill EM, Wang H, Nassif S, Esposito G, Ozdemirli M, Cordova C, Cheson BD. 18F-FDG PET-CT and Trephine Biopsy Assessment of Bone Marrow Involvement in Lymphoma. British Journal of Haematology. 2016. 174(3):410-6. doi: 10.1111/bjh.14071. PubMed PMID: 27098364.

  9. Gabrielson A, Wu Y, Wang H, Jiang J, Kallakury B, Fishbein T, Johnson L, Island E, Satoskar R, Banovac F, Jha R, Kachhela J, Feng P, Zhang T, Tesfaye A, Loffredo C, Marshall J, Weiner L, Atkins M, He R. Intratumoral CD3 and CD8 T-Cell Densities Associated with Relapse Free Survival in HCC. Cancer Immunology Research. 2016. 4(5):419-30. doi: 10.1158/2326-6066.CIR-15-0110. Epub 2016 Mar 11. PubMed PMID: 26968206.

  10. Paiva SP, Veloso CA, Campos FF, Carneiro MM, Tilan JU, Wang H, Umans JG, Zukowska Z, Kitlinska J. Elevated levels of neuropeptide Y in preeclampsia: a pilot study implicating a role for stress in pathogenesis of the disease. Neuropeptides. 2016 Feb; 55:127-35. doi: 10.1016/j.npep.2015.09.006. Epub 2015 Sep 25. PubMed PMID: 26431933. PubMed Central PMCID: PMC4755897.

See More...

 
  1. Wang H, Wang Y, Kota K, Kallakury B, Mikhail N, Abdel-Aziz M, Sayed D, Gouda I, Sobitan A, Sun B, Loffredo C, Zheng Y. Strong association between long and heterogeneous telomere length in blood lymphocytes and bladder cancer risk in Egyptian. Carcinogenesis. 2015 Nov; 36(11): 1284-90. doi:10.1093/carcin/bgv121. Epub 2015 Sep 5. PubMed PMID: 26342126. PubMed Central PMCID: PMC4635668.

  2. Lynce F, Smith KL, Stein J, DiMarco T, Wang Y, Wang H, Fries M, Peshkin BN, Isaacs C. Deleterious BRCA1/2 mutations in an urban population of Black women. Breast Cancer Research and Treatment. 2015 Aug; 153(1):201-9. doi: 10.1007/s10549-015-3527-8. Epub 2015 Aug 7. PubMed PMID: 26250392.

  3. Gabrielson A, Tesfaye A, Marshall J, Pishvaian M, Smaglo B, Jha R, Dorsch-Vogel K, Wang H, He R. Phase II study of temozolomide and veliparib combination therapy for sorafenib-refractory advanced hepatocellular carcinoma. Cancer Chemotherapy and Pharmacology. 2015 Nov; 76(5):1073-9. doi: 10.1007/s00280-015-2852-2. Epub 2015 Oct 8. PubMed PMID: 26449224. PubMed Central PMCID: PMC4612326.

  4. Walls A, Cubangbang M, Wang H, Raiji M, Knight J, Steehler M, Latimer E, Harley EH. Pediatric Autoimmune Neuropsychiatric Discorder Associated with Streptococcus Immunology A Pilot Study. Otolaryngology Head and Neck Surgery. 2015 Apr 1. doi: 10.1177/0194599815577784. PubMed PMID: 25832830.

  5. Deeken JF, Wang H, Marshall J, Subramaniam D, Hwang J, He AR, Urso C, Ramos C, Steadman K, Pishvaian MJ. A Phase I Study of Cetuximab and Lapatinib In Patients with Advanced Solid Tumor Malignancies. Cancer. 2015 May 15; 121(10): 1645-53. doi: 10.1002/cncr.29224. PubMed PMID: 25641763; PubMed Central PMCID: PMC4424139.

  6. Deeken JF, Newkirk K, Harter KW, Marshall B, Banovac F, Johnson L, Wang H, Wang Y, Zhuang T, Jay AK, Berkowitz F, Esposito G, Kallakury B, Davidson B. Effect of multimodality treatment on overall survival for patients with metastatic or recurrent HPV-positive head and neck squamous cell carcinoma. Head & Neck. 2015 May; 37(5): 630-5. doi: 10.1002/hed.23644. Epub 2014 Apr 30. PubMed PMID: 24616038.

  7. Woo J, Chen LN, Wang H, Cyr RA, Bhattasali O, Kim JS, Moures R, Yung T, Lei S, Collins BT, Suy S, Dritschilo A, Lynch JH, Collins P. Stereotactic Body Radiation Therapy for Prostate Cancer: What is the Appropriate Patient-Reported Outcome for Clinical Trial Design? Frontiers in Oncology. 2015 Mar 31; 5:77. doi: 10.3389/fonc.2015.00077. PubMed PMID: 25874188; PubMed Central PMCID: PMC4379875.

  8. Wang H. On Projection of Costs and Incremental Cost-Effectiveness Ratios: A Data Example. International Journal of Health Sciences. 2015 March 3(1): 189-198. doi: 10.15640/ijhs.v3n1a11.

  9. Zhi X, Lin L, Yang S, Bhuvaneshwar K, Wang H, Gusev Y, Kallakury B, Shivapurkar N, Cahn K, Tian X, Marshall J, Byers SW, He AR. βII-spectrin (SPTBN1) suppresses progression of hepatocellular carcinoma and Wnt signaling via regulation of Wnt inhibitor kallistatin. Hepatology. 2015 Feb; 61(2): 598-612. doi: 10.1002/hep.27558. PubMed PMID: 25307947; PubMed Central PMCID: PMC4327990.

  10. Walls A, Pierce M, Wang H, Steehler A, Steehler M, Harley EH. Response to the letter to the Editor regarding: Parental perception of speech and tongue mobility in three-year olds after neonatal frenotomy. International Journal of Pediatric Otorhinolaryngology. 2014 July; 78(7): 1195-6. doi: 10.1016/j.ijporl.2014.03.034.

  11. Chen LN, Suy S, Wang H, Bhagat A, Woo JA, Moures R, Kim J, Young T, Lei S, Collins BT, Kowalczyk K, Dritschilo A, Lynch J, Collins SP. Patient-Reported Urinary Incontinence Following Stereotactic Body Radiation Therapy (SBRT) for Clinically Localized Prostate Cancer. Radiation Oncology. 2014 Jun 26; 9:148, doi: 10.1186/1748-717X-9-148. PubMed PMID: 24966110; PubMed Central PMCID: PMC4083362.

  12. Yuan A, Wei Y, Makambi K, Wang H. Approximate Nonparametric Maximum Likelihood Estimation for Interval Censoring Model Case II. International Journal of Statistics and Probability. 2014; 3(3):44-64. doi:10.5539/ijsp.v3n3p44.

  13. Weinberg BA, Wang H, Yang X, Hwang J, Wu C, Pishvaian MJ, He AR, Marshall J. Maintenance therapy with capecitabine in patients with resected pancreatic adenocarcinoma after adjuvant therapy, a retrospective cohort study. Gastrointestinal Cancer Research. 2014 May-Aug; 7(3-4): 91-7. PubMed Central PMCID: PMC4171974.

  14. Ujjani C, Ramzi P, Gehan E, Wang H, Wang Y, Cheson BD. Ofatumumab and Bendamustine in Previously Treated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma. Leukemia and Lymphoma. 2015 Apr 56(4):915-20. doi: 10.3109/10428194.2014.933217. Epub 2014 Aug 6. PubMed PMID: 24925211.

  15. Tilan JU, Krailo M, Barkauskas D, Galli S, Mtaweh H, Long J, Wang H, Lu C, Jeha D, IzyckaSwieszewska E, Lawlor E, Toretsky J, Kitlinska J. Systemic levels of neuropeptide Y and dippetidyl peptidase activity in Ewing sarcoma patients – associations with tumor phenotype and survival. Cancer. 2015 Mar 1; 121(5): 697-707. doi: 10.1002/cncr.29090. Epub 2014 Nov 11. PubMed PMID: 25387699;PubMed Central PMCID: PMC4339539.

  16. Walls A, Pierce M, Wang H, Harley EH. Clothing Hanger Injuries: Pediatric Head and Neck Tramus In The United States, 2002-2012. Otolaryngology - Head and Neck Surgery. 2014 Feb; 150(2): 300-4. doi: 10.1177/0194599813514521. Epub 2013 Dec 6. PubMed PMID: 24316792.

  17. Walls A, Pierce M, Wang H, Harley EH. Parental perception of speech and tongue mobility in three year olds after neonatal frenotomy. International Journal of Pediatric Otorhinolaryngology. 2014 Jan; 78(1): 128-31. doi: 10.1016/j.ijporl.2013.11.006. Epub 2013 Nov 18. PubMed PMID: 24315215.

  18. Tilan JU, Lu C, Galli S, Iżycka-Świeszewska E, Earnest JP, Shabbir A, Everhart L, Wang S, Martin S, O’Neill A, Christian D, Wang H, Zhuang T, Czarnecka M, Johnson MD, Toretsky JA, Kitlinska J. Hypoxia shifts activity of neuropeptide Y in Ewings sarcoma from growth-inhibitory to growth promoting effects. Oncotarget. 2013 Dec; 4(12): 2487-501. PubMed PMID: 24318733; PubMed Central PMCID: PMC3926843.

  19. Sood S, Ju A, Wang H, Lei S, Uhm S, Zhang G, Suy S, Carroll J, Lynch J, Dritschilo A, Collins SP. Rectal endoscopy findings following stereotactic body radiation therapy for clinically localized prostate cancer. Radiation Oncology. 2013 Aug 9; 8:197. doi: 10.1186/1748-717X-8-197. PubMed PMID: 23937800; PubMed Central PMCID: PMC3751769.

  20. Holliday M, Tavaluc R, Zhuang T, Wang H, Davidson B. Oncologic benefit of tonsillectomy in Stage I and II tonsil cancer: A SEER database review. JAMA Otolaryngology - Head & Neck Surgery. 2013 Apr; 139(4):362-6. doi: 10.1001/jamaoto.2013.107. PubMed PMID: 23599071.

  21. Ju AW, Wang H, Oermann E, Sherer BA, Uhm S, Chen V, Pendharkar AV, Hanscom HN, Kim J, Lei S, Suy S, Lynch JH, Dritschilo A, Collins SP. Hypofractionated stereotactic body radiation therapy as monotherapy for intermediate-risk prostate cancer. Radiation Oncology. 2013 Jan; 8:30. doi:10.1186/1748-717X-8-30. PubMed PMID: 23369294; PubMed Central PMCID: PMC3570380.

  22. Yue W, Wang JP, Li Y, Fan P, Liu G, Zhang N, Conaway M, Wang H, Korach KS, Bocchinfuso W, Santen R. Effects of estrogen on breast cancer development: Role of estrogen receptor independent mechanisms. Int J Cancer. 2010 Oct 15;127(8):1748-57.

  23. Schroen AT, Petroni GR, Wang H, Gray R, Wang XF, Cronin W, Sargent DJ, Benedetti J, Wickerham DL, Djulbegovic B, Slingluff CL Jr. Preliminary evaluation of factors associated with premature trial closure and feasibility of accrual benchmarks in phase III oncology trials. Clin Trials. 2010 Aug;7(4):312-21. Epub 2010 Jul 1.

  24. Turrentine FE, Wang H, Young JS, Calland JF. What is the safety of nonemergent operative procedures performed at night? A study of 10,426 operations at an academic tertiary care hospital using the American College of Surgeons national surgical quality program improvement database. J Trauma. 2010 Aug;69(2):313-9.